Clinical research

Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale

EuroIntervention 2013;9:629-635. DOI: 10.4244/EIJV9I5A100

Xavier Freixa
Xavier Freixa, MD; Réda Ibrahim, MD; Jason Chan, MD; Patrick Garceau, MD; Annie Dore, MD; Francois Marcotte, MD; Lise-Andree Mercier, MD; Francois-Pierre Mongeon, MD; Arsène Basmadjian, MD; Paul Khairy, MD, PhD; Anita W. Asgar*, MD
Department of Cardiology, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada

Aims: To describe the initial experience with the GORE® septal occluder (GSO), a new septal occluder for the treatment of atrial septal defects (ASD) and pat

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

asd closuregso devicepfo closure
Read next article
Emergency transseptal transcatheter mitral valve-in-valve implantation

Latest news